Edwards Lifesciences Corp. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains

Dow Jones03-27

DJ Edwards Lifesciences Corp. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Edwards Lifesciences Corp. $(EW)$ inched 0.28% higher to $93.42 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index $(SPX.UK)$ falling 0.28% to 5,203.58 and Dow Jones Industrial Average $(DJIA)$ falling 0.08% to 39,282.33.

The stock's rise snapped a two-day losing streak.

Edwards Lifesciences Corp. closed $1.85 below its 52-week high ($95.27), which the company reached on March 14th.

The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Abbott Laboratories $(ABT)$ rose 1.35% to $111.50, Medtronic PLC $(MDT)$ rose 0.55% to $83.70, and Stryker Corp. $(SYK)$ fell 0.19% to $350.38.

Data source: Dow Jones Market Data, FactSet. Data compiled March 26, 2024.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

March 26, 2024 16:51 ET (20:51 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment